Pharmacology, Toxicology and Pharmaceutical Science
Tenofovir Disoproxil
100%
Tumor Microenvironment
100%
Liposome
100%
Drug Release
100%
Hepatitis B Virus
80%
Malignant Neoplasm
62%
Retinoic Acid
44%
Immunotherapy
25%
RNA Directed DNA Polymerase Inhibitor
20%
Hepatitis B Antigen
20%
Adeno Associated Virus
20%
Hepatitis B(e) Antigen
20%
Sustained Release
12%
Systemic Circulation
12%
Neoplasm
12%
Controlled Drug Release
12%
Tumor Growth
12%
Immunomodulation
12%
Cornea Perforation
11%
Intramuscular Injection
10%
Immunology and Microbiology
Electroporation
100%
DNA Immunization
100%
Lipid Composition
50%
Nonviral Gene Delivery System
50%
Muscle Cell
50%
DNA Vaccination
33%
Systemic Circulation
16%
Controlled Drug Release
16%
Drug Accumulation
16%
Bispecific Antibody
13%
CD3 Antigen
13%
Peripheral Blood Mononuclear Cell
13%
Antibody Blood Level
11%
Immunofluorescence
11%
Th1 Cell
11%
Cancer Staging
11%
Single-Chain Variable Fragment
6%
Cytolysis
6%
Heavy Chain
6%
Nomenclature
6%
Medicine and Dentistry
mRNA Vaccine
100%
Vaccine Immunogenicity
100%
Bispecific Antibody
13%
CD3 Antigen
13%
Therapeutic Window
13%
Injection Site
10%
Intramuscular Injection
10%
Antigen Recognition
10%
Nonviral Gene Delivery System
10%
Heavy Chain
6%
Macrogol Derivative
6%
Cytolysis
6%